Oncoinvent ASA logo

Oncoinvent ASA (0RU5)

Market Open
15 Oct, 03:30 PM
LSE LSE
kr
67. 80
-0.4
-0.5865%
kr
- Market Cap
- P/E Ratio
- Div Yield
1,100 Volume
- Eps
kr 68.2
Previous Close
Add Transaction
Day Range
67.8 67.8
Year Range
0.44 141.5
Want to track 0RU5 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Oncoinvent ASA (0RU5) Statistics

Valuation metrics

Market Cap -
Enterprise value 208.75M
Trailing P/E (ttm) -0.84
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 16.07
Price/Book (mrq) 3.89
Enterprise Value/Revenue 10.7
Enterprise Value/EBITDA -1.39

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.66K
Average volume (90 days) 786

Price summary

52-Week low 0.44
52-Week high 141.5
Beta -
50-Day moving average 105.26
200-Day moving average 69

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.01:1
Last split Date 30 May 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -8.77%
Operating margin -8.12%

Operational effectiveness

Return on assets -1.33%
Return on equity -1.51%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 4.36
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -38.22
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 23.84
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 2.43%
Book value per share (mrq) 18.01

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -